Skip to content

<img width="182" height="68" src="https://eupa.org/wp-content/uploads/2016/11/EuPA-1-182x68.png" class="custom-logo" alt="" decoding="async" srcset="https://eupa.org/wp-content/uploads/2016/11/EuPA-1-182x68.png 182w, https://eupa.org/wp-content/uploads/2016/11/EuPA-1-300x112.png 300w, https://eupa.org/wp-content/uploads/2016/11/EuPA-1.png 400w" sizes="(max-width: 182px) 100vw, 182px" />

About Us
YPIC
- The challenge
- Board and core members
Initiatives
Awards
Education
Events
Newsletter
Shop
Jobs
Contact

<img width="182" height="68" src="https://eupa.org/wp-content/uploads/2016/11/EuPA-1-182x68.png" class="custom-logo" alt="" decoding="async" srcset="https://eupa.org/wp-content/uploads/2016/11/EuPA-1-182x68.png 182w, https://eupa.org/wp-content/uploads/2016/11/EuPA-1-300x112.png 300w, https://eupa.org/wp-content/uploads/2016/11/EuPA-1.png 400w" sizes="(max-width: 182px) 100vw, 182px" />

About Us
YPIC
- The challenge
- Board and core members
Initiatives
Awards
Education
Events
Newsletter
Shop
Jobs
Contact

Biotherapeutic protein characterisation with LC-MS

Finland news / October 21, 2016

insight to Biosimilars and comparability

April 20 – 22, 2015 in Vienna, Austria

Practical seminar

Post navigation

← Previous Post

Copyright © 2024 EuPA

Impressum
Newsletter
Privacy
Contact

Scroll to Top